Rigel Pharmaceuticals
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Rigel has 2 FDA approved products: 1. TAVALISSE (fostamatinib disodium hexahydrate) tablets was approved in 2018. Please visit www.TAVALISSEhcp.com to see the Full Prescribing Information to learn more. 2. REZLIDHIA (olutasidenib) capsules was approved in 2022. Please visit www.REZLIDHIAhcp.com to see the Full Prescribing Information, including Boxed WARNING to learn more.